{"title":"ASCO21 -肾癌亮点","authors":"J. Graham","doi":"10.52733/kcj19n2-s1-a13","DOIUrl":null,"url":null,"abstract":"With the virtual ASCO21 meeting behind us, we can now pause and reflect on the data presented. This year’s program contained a number of exciting abstracts in the kidney cancer space, including potentially practice changing results in the adjuvant setting. In this article, I will highlight some of the most interesting abstracts related to kidney cancer/renal cell carcinoma, including those presented in the poster, oral, and plenary sessions.","PeriodicalId":74040,"journal":{"name":"Kidney cancer journal : official journal of the Kidney Cancer Association","volume":"133 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"ASCO21 – Kidney Cancer Highlights\",\"authors\":\"J. Graham\",\"doi\":\"10.52733/kcj19n2-s1-a13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"With the virtual ASCO21 meeting behind us, we can now pause and reflect on the data presented. This year’s program contained a number of exciting abstracts in the kidney cancer space, including potentially practice changing results in the adjuvant setting. In this article, I will highlight some of the most interesting abstracts related to kidney cancer/renal cell carcinoma, including those presented in the poster, oral, and plenary sessions.\",\"PeriodicalId\":74040,\"journal\":{\"name\":\"Kidney cancer journal : official journal of the Kidney Cancer Association\",\"volume\":\"133 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney cancer journal : official journal of the Kidney Cancer Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52733/kcj19n2-s1-a13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney cancer journal : official journal of the Kidney Cancer Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52733/kcj19n2-s1-a13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
With the virtual ASCO21 meeting behind us, we can now pause and reflect on the data presented. This year’s program contained a number of exciting abstracts in the kidney cancer space, including potentially practice changing results in the adjuvant setting. In this article, I will highlight some of the most interesting abstracts related to kidney cancer/renal cell carcinoma, including those presented in the poster, oral, and plenary sessions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
